Skip to main content
Clinical Trials/NCT06420258
NCT06420258
Recruiting
Phase 4

A Study on the Effectiveness and Safety of Intratracheal Deep Intubation Compared to Traditional Tracheal Intubation in Endoscopic Submucosal Dissection for Early Esophageal Cancer in the Cervical Esophagus: A Randomized Controlled Trial.

Fujian Provincial Hospital1 site in 1 country40 target enrollmentOctober 1, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Carcinoma in Situ of Cervical Part of Esophagus
Sponsor
Fujian Provincial Hospital
Enrollment
40
Locations
1
Primary Endpoint
the rate of complete resection and postoperative stricture
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

To compare the efficacy and safety of intratracheal deep intubation with traditional intubation in endoscopic submucosal dissection for early esophageal cancer in the cervical esophagus, and to follow up and assess their short-term clinical outcomes.

Detailed Description

Forty patients with early esophageal cancer in the cervical esophagus scheduled for endoscopic submucosal dissection will be included. They will be randomly divided into two groups using sealed envelopes: approximately 20 patients in the intratracheal deep intubation group and 20 patients in the traditional intubation group. By comparing the operation time, perioperative complications, postoperative short-term complications, and other outcomes, we aim to elucidate the effectiveness and safety of deep intubation in endoscopic submucosal dissection for early esophageal cancer in the cervical esophagus.

Registry
clinicaltrials.gov
Start Date
October 1, 2022
End Date
December 31, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Wei Liang

Doctor

Fujian Provincial Hospital

Eligibility Criteria

Inclusion Criteria

  • The lesions mainly involve superficial esophageal squamous cell carcinoma or high-grade intraepithelial neoplasia (HGIN) in the cervical esophagus;
  • There is no evidence of regional lymph node or distant metastasis on endoscopic ultrasound (EUS) or CT/MRI imaging;
  • Participants have a thorough understanding of this study and voluntarily sign the informed consent form.

Exclusion Criteria

  • Patients who have received radiotherapy or chemotherapy before endoscopic submucosal dissection surgery;
  • Patients with severe comorbidities who are not suitable for endoscopic submucosal dissection surgery.

Outcomes

Primary Outcomes

the rate of complete resection and postoperative stricture

Time Frame: Seven days and three months after ESD procedure

Secondary Outcomes

  • ESD procedural time and other procedure-related complications(During procedures and just after ESD procedure.)

Study Sites (1)

Loading locations...

Similar Trials